Settlement of Pharma Disputes and Competition Law in Korea
|
|
- Sheryl Watts
- 5 years ago
- Views:
Transcription
1 Settlement of Pharma Disputes and Competition Law in Korea October 22, 2012 Monica Hyon-Kyong Leeu AIPPI PHARMA WORKSHOP I
2 Topics Patent Disputes in Korean Pharma Industry Korean Competition Law and KFTC s IPR Guidelines KFTC s Investigation Future Changes 1
3 Drug Lifecycle and Patent Disputes Generic Drug Approval before Patent Expiration Post-Marketing Surveillance Expiration Generic Approval/Pricing Generic Marketing Original Drug Patent Expiration Stage 3 Original Approval Original Pricing/Marketing Stage 2 Stage 1 Patent Disputes 2
4 Original Drug Price Linked to Generic Entry Pricing System (Dec 2006) Recent Reform (Feb 2012) When 1 st generic is listed (80*0.8) 61.2 (68*0.9) (61.2*0.9) When 1 st generic is listed (70*0.85) (59.5*0.9) After 12 months / 3 generics 0 original original when 1 st generic is listed 1 st -5 th generics 6 th generic 7 th generic 0 Previous price of original original when 1 st generic is listed 1 th generic all drugs 3
5 Increase in Pharma Patent Disputes Number of Patent Trials and Lawsuits Number of cases Scope Confirmation Trial Damage Action Correction Trial Invalidation Trial Preliminary Injunction Others Permanent injunction Opposition Total [KFTC Report in Case No ] 4
6 Korean Competition Law Monopoly Regulation and Fair Trade Law ( FTL ) enacted in 1980 Abuse of Dominance and Restrictive Practices (Unilateral Conduct /Unfair Trade Practice) Mergers and Acquisitions Regulated Activities Cartels Others (Sub-contracting, Unfair Advertising, etc.) Abuse of Intellectual Property Rights 5
7 Korea Fair Trade Commission Approximately 500 personnel; 5 regional offices Broad investigative and enforcement power comparable to that of EC Dawn raids, summoning respondents/witnesses, seizure of evidence One of the most active competition authorities in the world Sensitive to global trends of antitrust law enforcement Various methods of enforcement Cease and desist orders Surcharges, Administrative fines Public announcement of violation Filing of criminal complaint 6
8 KFTC Guidelines on IPR Abuse Legitimate exercise of IP rights NOT affected by the FTL (Article 59) Not only domestic companies but also foreign companies if the acts of those companies had impact on Korean market Generally, rule of reason: efficiency vs. anti-competitive effects Types of IPR abuse Refusal to grant license or restrictions in license Patent pools and cross-licenses Exercise of patent rights in relation to technology standards Abuse of patent litigation Unfair settlement of patent litigation Assignment of patent rights constituting a major business 7
9 KFTC Guidelines Unfair Patent Settlements Factors to Consider Are the parties competitors? Is the purpose of settlement to restrict competition in the relevant market? Is market entry by the party delayed beyond the patent term? Is entry into a market not directly related to the patentbeing delayed? OR Are the parties aware or is it objectively obvious that the disputed patent is invalid? 8
10 KFTC s IPR Investigation June 2010 August 2010 ~ Early 2011 October 2011 Status survey sent to 48 companies in pharma industry Status survey sent to 59 companies in IT industry On-site investigations and additional questionnaires sent to companies in pharma and IT industries Status survey sent to 31 companies in chemical and machinery industries Ongoing examinations Ongoing investigations 9
11 KFTC s Investigation of Pharma Industry Status Survey in 2010 Covering activities during Questions about ever-greening strategy in patent filings, patent disputes to block generic entry, restrictive terms in agreements for 220 APIs On-Site Investigation in 2011 Focus on whether abuse of IP rights resulted in unfair exclusion of competitors Finding of a reverse payment issue 10
12 Competition Policy vs. IPR Protection Settlements allow for the safeguard of profits guaranteed by IP law, reinforce legal certainty and protect incentives to continue to develop new drugs In the short run, a competition policy may result in more competition in the market, but in the long run, it can undermine the incentives to engage in R&D Need a balance between competition policy and IPR protection 11
13 Patent-Approval Linkage Antitrust Implications Under Korea-US FTA: new patent-approval linkage system March 15, 2012: Patent listing & generic notice (1 st phase) March 15, 2015: Stay of generic approval (2 nd phase) Will first generic exclusivity be included? How long? More antitrust scrutiny? 12
14 KFTC s Future Plans We will strengthen enforcement against reverse payment settlements in the pharmaceutical industry Chairman, Mr. Dongsoo Kim Plan to enact a requirement that pharmaceutical patent settlement agreements be submitted to KFTC for review 13
15 Practical Considerations for Patent Settlements Any settlement agreement of a patent dispute may be submitted to KFTC Review potential FTL issues before entering into a settlement agreement Need to closely monitor antitrust cases and issues in other jurisdictions 14
16 Thank you I n t e l l e c t u a l P r o p e r t y Monica Hyon-Kyong Leeu Direct: hkleeu@ip.kimchang.com
B) Issues to be Prioritised within the Proposed Global Strategy and Plan of Action:
INTERGOVERNMENTAL WORKING GROUP ON PUBLIC HEALTH, INNOVATION AND INTELLECTUAL PROPERTY EGA Submission to Section 1 Draft Global Strategy and Plan of Action The European Generic Medicines Association is
More informationIssues at the Intersection of IP and Competition Policy
Issues at the Intersection of IP and Competition Policy WIPO Symposium 11 May 2010 Jeremy West OECD Competition Division jeremy.west@oecd.org The Big Picture IP and competition policy are mostly complementary,
More informationIntellectual property and competition policy
EUROPEAN COMMISSION Joaquín Almunia Vice President of the European Commission responsible for Competition Policy Intellectual property and competition policy IP Summit 2013 (Paris) 9 December 2013 SPEECH/13/1042
More informationONLINE INTELLECTUAL PROPERTY COURSES BY FEDERATION OF INDIAN CHAMBERS OF COMMERCE AND INDUSTRY (FICCI) About FICCI Established in 1927, FICCI is the largest and oldest apex business organisation in India.
More informationU.S. Patent-Antitrust Interface. Alden F. Abbott, Heritage Foundation Oxford Competition Law Centre June 28, 2014
U.S. Patent-Antitrust Interface Alden F. Abbott, Heritage Foundation Oxford Competition Law Centre June 28, 2014 Introduction My thesis is that antitrust law has gradually weakened U.S. patent rights in
More information5 th Annual Pharma IPR Conference 2016
5 th Annual Pharma IPR Conference 2016 9 11 March 2016, Mumbai DAY 1 : 9 th March 2016 Country: US 09:40 American Invents Act Updates on Americas Invents Act and current scenario of US Patent laws Implications
More informationApril 21, By to:
April 21, 2017 Mr. Qiu Yang Office of the Anti-Monopoly Commission Of the State Council of the People s Republic of China No. 2 East Chang an Avenue, Beijing P.R. China 100731 By Email to: qiuyang@mofcom.gov.cn
More informationFTC Approves Nielsen-Arbitron Transaction with Licensing and Divestiture Remedies
WRITTEN BY M. BRINKLEY TAPPAN AND LOGAN M. BREED SEPTEMBER 16-22, 2013 MERGERS & ACQUISITIONS FTC Approves Nielsen-Arbitron Transaction with Licensing and Divestiture Remedies On September 20, the FTC
More informationLAW ON TECHNOLOGY TRANSFER 1998
LAW ON TECHNOLOGY TRANSFER 1998 LAW ON TECHNOLOGY TRANSFER May 7, 1998 Ulaanbaatar city CHAPTER ONE COMMON PROVISIONS Article 1. Purpose of the law The purpose of this law is to regulate relationships
More informationCarnegie Endowment for International Peace
Carnegie Endowment for International Peace How the U.S. and India could Collaborate to Strengthen Their Bilateral Relationship in the Pharmaceutical Sector Second Panel: Exploring the Gilead-India Licensing
More informationObservations from Pharma
Observations from Pharma Indian Patent Enforcement in the Chemical Arts Gurmeet Kaur Sidhu, Senior Patent Litigation Counsel London, 26/9/11 a Novartis company The Indian Pharmaceutical sector: Overview
More informationManmin. IP & LAW Firm
Manmin IP & LAW Firm Who are you thinking of putting on your valuable IP rights? Reliable service in Intellectual Property To success in the global market, it is necessary to value your IP rights correctly
More informationGlobalizing IPR Protection: How Important Might RTAs Be?
Globalizing IPR Protection: How Important Might RTAs Be? Keith Maskus, University of Colorado Boulder (keith.maskus@colorado.edu) NAS Innovation Policy Forum National and International IP Policies and
More informationDr. Biswajit Dhar Professor, Jawaharlal Nehru University, India and Member DA9 Advisory Board
Dr. Biswajit Dhar Professor, Jawaharlal Nehru University, India and Member DA9 Advisory Board Intellectual Property Rights in Preferential Trade Agreements Many Preferential Trade Agreements (PTAs) adopted
More informationLitigators for Innovators
Litigators for Innovators Concord, MA: 530 Virginia Rd., Concord, MA 01742 Boston, MA: 155 Seaport Blvd., Boston, MA 02210 T: 978-341-0036 T: 617-607-5900 www.hbsr.com www.litigatorsforinnovators.com 9/13
More information2010/IPEG/SYM/007 IP Commercialization in Korea - From Research and Development to Commercialization
2010/IPEG/SYM/007 IP Commercialization in Korea - From Research and Development to Commercialization Submitted by: Korea Innovating Intellectual Property Exploitation Symposium Sendai, Japan 9 September
More informationContents. 1 Introduction... 1
Contents 1 Introduction... 1 Part I Startup Funding Sources, Stages of the Life Cycle of a Business, and the Corresponding Intellectual Property Strategies for Each Stage 2 Sources of Company Funding...
More informationOrganisation de Coopération et de Développement Économiques Organisation for Economic Co-operation and Development
Unclassified DAF/COMP/M(2014)2/ANN6/FINAL DAF/COMP/M(2014)2/ANN6/FINAL Unclassified Organisation de Coopération et de Développement Économiques Organisation for Economic Co-operation and Development 10-Feb-2015
More informationHow Japanese Businesses Should Handle China s Emerging Approach to Antitrust and Intellectual Property
*If you would like to quote from this presentation, please contact us in advance. Conference Section, RIETI (TEL: +81-3-3501-8398) How Japanese Businesses Should Handle China s Emerging Approach to Antitrust
More informationWIPO Sub-Regional Workshop on Patent Policy and its Legislative Implementation
WIPO Sub-Regional Workshop on Patent Policy and its Legislative Implementation Topic 2: The Patent system Policy objectives of the patent system Ways and means to reach them Marco M. ALEMAN Deputy Director,
More informationGuidelines on Standardization and Patent Pool Arrangements
Guidelines on Standardization and Patent Pool Arrangements Part 1 Introduction In industries experiencing innovation and technical change, such as the information technology sector, it is important to
More informationTRIPS-Plus Provisions and Access to Technologies:
TRIPS-Plus Provisions and Access to Technologies: Implications for the Trans-Pacific Partnership Walter G. Park, American University 11 May 2012 Outline Notion of Optimal IPRs IPRs and Technology Transfer
More informationStrategic Patenting and Registration of Healthcare Products
Strategic Patenting and Registration of Healthcare Products Conference EU Competition Law in Sales and Distribution of Healthcare Products University of Basel, Faculty of Law, 19 May 2017 Professor Dr
More informationSocial returns to direct private innovation support: the patent system
Social returns to direct private innovation support: the patent system Bhaven N Sampat (Columbia University and NBER) 12/15/16 Senate Judiciary Study #1 (December 20, 1956) Senate Judiciary Study #1 (December
More informationAntitrust & Competition
Antitrust & Competition Mayer Brown s multi-disciplinary Antitrust & Competition team offers a seamless, coordinated service throughout the Asia Pacific region, and has the benefit of extensive regional
More informationPhilip Monaghan Partner
Philip Monaghan Partner Hong Kong D: +852-3512-2368 pmonaghan@omm.com Philip is a former senior competition regulator who, in private practice, advises Asia-based and multinational clients on competition
More informationFlexibilities in the Patent System
Flexibilities in the Patent System Dr. N.S. Gopalakrishnan Professor, HRD Chair on IPR School of Legal Studies, Cochin University of Science & Technology, Cochin, Kerala 1 Introduction The Context Flexibilities
More informationDRAFT AGENDA. OECD/Korean Policy Centre. Workshop on Merger Review Procedures and Joint Ventures. MOFCOM - Beijing, 25 June 2014
DRAFT AGENDA OECD/Korean Policy Centre Workshop on Merger Review Procedures and Joint Ventures MOFCOM - Beijing, 25 June 2014 9.00 09.40 Opening Remarks and Introduction of the OECD/Korea Policy Centre
More informationPublic Hearings Concerning the Evolving Intellectual Property Marketplace
[Billing Code: 6750-01-S] FEDERAL TRADE COMMISSION Public Hearings Concerning the Evolving Intellectual Property Marketplace AGENCY: Federal Trade Commission. ACTION: Notice of Public Hearings SUMMARY:
More informationSlide 25 Advantages and disadvantages of patenting
Slide 25 Advantages and disadvantages of patenting Patent owners can exclude others from using their inventions. If the invention relates to a product or process feature, this may mean competitors cannot
More informationPatents and innovation (and competition) Bronwyn H. Hall UC Berkeley, U of Maastricht, NBER, and IFS London
Patents and innovation (and competition) Bronwyn H. Hall UC Berkeley, U of Maastricht, NBER, and IFS London Patent system as viewed by a two-handed economist Effects on Innovation Competition Positive
More informationPatents as a regulatory tool
Patents as a regulatory tool What patent offices can do to promote innovation UNECE Team of Specialists on Intellectual Property 'Intellectual Property and Competition Policy' Geneva, 21 June 2012 Nikolaus
More informationeskbook Emerging Life Sciences Companies second edition Chapter 8 Checklist for Planning and Conducting an Effective FTO Search
eskbook Emerging Life Sciences Companies second edition Chapter 8 Checklist for Planning and Conducting an Effective FTO Search Chapter 8 CHECKLIST FOR PLANNING AND CONDUCTING AN EFFECTIVE FTO SEARCH The
More information19 Progressive Development of Protection Framework for Pharmaceutical Invention under the TRIPS Agreement Focusing on Patent Rights
19 Progressive Development of Protection Framework for Pharmaceutical Invention under the TRIPS Agreement Focusing on Patent Rights Research FellowAkiko Kato This study examines the international protection
More informationIntellectual Property
Intellectual Property 1 Overview In a progressively uncertain economy, counterfeit products are becoming more prevalent particularly in Vietnam. Therefore, companies should be increasingly vigilant in
More informationUNCITRAL Third International Colloquium on Secured Transactions Session on Contractual Guide on IP Licensing (Vienna, March 3, 2010)
UNCITRAL Third International Colloquium on Secured Transactions Session on Contractual Guide on IP Licensing (Vienna, March 3, 2010) Basic contractual requirements on PATENT LICENSING Laurent Manderieux
More informationPharmaceutical Sector Inquiry
EUROPEAN COMMISSION Competition DG Pharmaceutical Sector Inquiry Preliminary Report (DG Competition Staff Working Paper) Executive Summary 28 November 2008 EXECUTIVE SUMMARY A. Introduction and Overview
More informationFinal results of the Commission pharmaceutical sector inquiry: competition and regulatory concerns to address
Final results of the Commission pharmaceutical sector inquiry: competition and regulatory concerns to address Fabio Domanico and Elena Kamilarova ( 1 ) On 8 July 2009, the Commission presented the final
More informationPatent Misuse. History:
History: Patent Misuse Origins in equitable doctrine of unclean hands Gradually becomes increasingly associated with antitrust analysis Corresponding incomplete transition from fairness criterion to efficiency
More informationBIPF Munich. South Africa Enforcement of Pharmaceutical Patents and the New Draft IP Policy
BIPF 2014 - Munich South Africa Enforcement of Pharmaceutical Patents and the New Draft IP Policy Russell Bagnall Danie Dohmen 1 OVERVIEW Enforcement of Pharmaceutical Patents The Role Players Compulsory
More informationBloomberg BNA Professional Learning Legal Course Catalog OnDemand Programs
Bloomberg BNA Professional Learning Legal Course Catalog OnDemand Programs Antitrust 1. Anti-Counterfeiting for Licensed Products: What You Don't Know Can Hurt Your Business 2. Antitrust Investigations:
More informationTRAINING SEMINAR PHARMACEUTICALS AND INTELLECTUAL PROPERTY ACCESS TO MEDICINE: Exploitation of pharmaceutical patents: compulsory licences SESSION 4
TRAINING SEMINAR PHARMACEUTICALS AND INTELLECTUAL PROPERTY 1 12 14 March 2012 Pretoria, South Africa SESSION 4 ACCESS TO MEDICINE: COMMERCIALISATION, DISTRIBUTION, COMPETITION ----------------- Exploitation
More informationProtecting Your Trade Secrets in Silicon Valley and Beyond
Protecting Your Trade Secrets in Silicon Valley and Beyond Jeffrey D. Polsky, Esq., Partner, Fox Rothschild LLP May 8, 2017 1 Types of Intellectual Property Trademark a recognizable sign, design, or expression
More informationIP Issues in Antimonopoly Review of Undertaking Concentration
IP Issues in Antimonopoly Review of Undertaking Concentration Unconditionally Cleared Cases that involed IP Rights Issues For example, Google s acquisition of Motorola; Microsoft s acquisition of Nokia;
More informationRosatom Approach to IPR Management in Collaborative Projects on Innovations
State Atomic Energy Corporation Rosatom Rosatom Approach to IPR Management in Collaborative Projects on Innovations Natalia Belenkaya Project Leader, Innovation Management ROSATOM Vienna, IAEA November
More informationIPRs and Public Health: Lessons Learned Current Challenges The Way Forward
Local Pharmaceutical Production in Africa International Conference Cape Town, 4-6 April 2011 IPRs and Public Health: Lessons Learned Current Challenges The Way Forward Roger Kampf WTO Secretariat 1 Acknowledging
More informationNavigating the Globe: Cartel Enforcement Around the World
Navigating the Globe: Cartel Enforcement Around the World Chapter 5: Korea Presented by the Cartel and Criminal Practice Committee and the International Committee September 13, 2012 Presenters Douglas
More informationArlindo Oliveira. An Intellectual Property Strategy supporting Open Innovation
Arlindo Oliveira An Intellectual Property Strategy supporting Open Innovation The innovation process Why do we need open innovation? "The most successful organizations co-create products and services with
More informationIssues and Possible Reforms in the U.S. Patent System
Issues and Possible Reforms in the U.S. Patent System Bronwyn H. Hall Professor in the Graduate School University of California at Berkeley Overview Economics of patents and innovations Changes to US patent
More informationChina: Patent LAW. Randall Rader Tsinghua University Professor and Advisory Board Chair
China: Patent LAW Randall Rader Tsinghua University Professor and Advisory Board Chair THE GOOD NEWS China really believes in Patents 2 THE BAD NEWS: China really believes in Patents 3 GOOD NEWS 4 Patent
More information1. History of IP in JAPAN
From Invention To Patent Protecting New and Innovative Ideas for Launching New Products and Exploiting Patent Information for Business Development ( WIPO Sub-Regional Workshop ) December, 00 Takao OGIYA
More informationChina: Managing the IP Lifecycle 2018/2019
China: Managing the IP Lifecycle 2018/2019 Patenting strategies for R&D companies Vivien Chan & Co Anna Mae Koo and Flora Ho Patenting strategies for R&D companies By Anna Mae Koo and Flora Ho, Vivien
More informationPLANNING YOUR COURSE OF STUDY (JURIS DOCTOR)
PLANNING YOUR COURSE OF STUDY (JURIS DOCTOR) This list is provided to aid students in planning their course of study. The law school anticipates offering these courses during the listed semesters. Students
More informationANTITRUST & COMPETITION PRACTICE GROUP
ANTITRUST & COMPETITION ANTITRUST & COMPETITION YOON & YANG LLC ANTITRUST & COMPETITION Yoon & Yang LLC Yoon & Yang has many lawyers and other professionals who are experts and specialists in their respective
More informationRocco E. Testani, Partner
, Partner 999 Peachtree Street, NE Suite 2300 Atlanta, GA 30309-3996 Office: 404.853.8390 rocco.testani@sutherland.com Rocco Testani represents clients in litigation ranging from complex business disputes
More informationWIPO: Working on the balance
WIPO: Working on the balance Use and Abuse of IP and Related Rights : Getting the Right Balance Second Session October 17, 2010 Matthew Bryan, Director, Patent Cooperation Treaty Legal Division Trolls
More informationFunctionality of the Nagoya ABS Protocol with a view to AnGR and a side-look to Anti- Conterfeiting Trade Agreement (ACTA)
Functionality of the Nagoya ABS Protocol with a view to AnGR and a side-look to Anti- Conterfeiting Trade Agreement (ACTA) Morten Walløe Tvedt Senior research fellow International Technical Expert Workshop
More informationPatents and Business Strategies A Patent Attorney s Perspective
Patents and Business Strategies A Patent Attorney s Perspective Safet Metjahic McGuireWoods LLP 1 Patents and Business Strategies What IP to protect, what IP to acquire and what IP to license/sell Strategies
More informationUSTR NEWS UNITED STATES TRADE REPRESENTATIVE. Washington, D.C UNITED STATES MEXICO TRADE FACT SHEET
USTR NEWS UNITED STATES TRADE REPRESENTATIVE www.ustr.gov Washington, D.C. 20508 202-395-3230 FOR IMMEDIATE RELEASE August 27, 2018 Contact: USTR Public & Media Affairs media@ustr.eop.gov UNITED STATES
More informationUNITAID The HIV/AIDS Medicines Patent Pool Initiative Overview
UNITAID The HIV/AIDS Medicines Patent Pool Initiative Overview December 2009 UNITAID Mission UNITAID's Mission Scale up access to treatment for HIV/AIDS, malaria and TB Leverage price reductions of quality
More informationTrade Secret Protection of Inventions
Trade Secret Protection of Inventions Phil Marcoux & Kevin Roe Inventions - Trade Secret or Patent? Theft by employees, executives, partners Theft by contract Note - this class does not create an attorney-client
More informationForeign Filing Strategies - Considerations in Protecting Your Patents Globally
Foreign Filing Strategies - Considerations in Protecting Your Patents Globally Gwilym Attwell Fish & Richardson Patent Webinar Series February 26, 2014 #fishwebinar Foreign filing Considerations Where
More information"Competition Policy and Intellectual Property Rights in the Republic of Latvia since 1991" (the working title)
"Competition Policy and Intellectual Property Rights in the Republic of Latvia since 1991" (the working title) Research Proposal for the Doctoral Course at the "Ostsee-Kolleg: Baltic Sea School Berlin",
More informationKey Strategies for Your IP Portfolio
Key Strategies for Your IP Portfolio Jeremiah B. Frueauf, Partner Where s the value?! Human capital! Physical assets! Contracts, Licenses, Relationships! Intellectual Property Patents o Utility, Design
More informationThe role of IP in economic development: the case of China
The role of IP in economic development: the case of China Albert G. Hu Department of Economics National University of Singapore Prepared for ARTNeT / WTO Research Workshop on Emerging Trade Issues in Asia
More informationJudicial System in Japan (IP-related case)
Session1: Basics of IP rights International Workshop on Intellectual Property, Commercial and Emerging Laws 24 Feb. 2017 Judicial System in Japan (IP-related case) Akira KATASE Judge, IP High Court of
More informationAre Government Sources Reliable Evidence that Pioneer Patents Block Downstream Development?
Are Government Sources Reliable Evidence that Pioneer Patents Block Downstream Development? Ron D. Katznelson, Ph.D.* President, Bi-Level Technologies, Encinitas, CA CPIP 6th Annual Fall Conference OCTOBER
More informationHamilton Loeb. Washington, D.C. Practice Areas. Admissions. Languages. Education. Partner, Litigation Department
Hamilton Loeb Partner, Litigation Department hamiltonloeb@paulhastings.com Hamilton Loeb is a partner in the Litigation practice of Paul Hastings and is based in the firm s Washington, D.C., office. His
More informationIntellectual property governance and strategic value creation:
Intellectual property governance and strategic value creation: some evidence from European organizations in, pharmaceutical and public research fields Dr. Federica Rossi (rossi.federica@unito.it) Universita
More informationTopic 2: Patent-related Flexibilities in Multilateral Treaties and Their Importance for Developing Countries and LDCs
Topic 2: Patent-related Flexibilities in Multilateral Treaties and Their Importance for Developing Countries and LDCs McLean Sibanda Chief Executive Officer - The Innovation Hub Second WIPO Inter-Regional
More informationRiccardo Celli Partner
Riccardo Celli Partner Brussels D: +32-2-642-41-34 rcelli@omm.com Riccardo Celli is Chair of O Melveny s European Antitrust and Competition Practice and the Regional Head of Litigation for Europe. Riccardo
More informationPatients Must Have Immediate Access to Affordable Generic Medicines at Day One After Patent Expiry
Patients Must Have Immediate Access to Affordable Generic Medicines at Day One After Patent Expiry Generic Medicines: Key to Healthcare Sustainability and Patient Care EGA represents over 700 companies
More informationThe Interdisciplinary Centre for Competition Law and Policy (ICC) and Crowell & Moring LLP Annual Conference 2014
The Interdisciplinary Centre for Competition Law and Policy (ICC) and Crowell & Moring LLP Annual Conference 2014 Trends and Developments in Global Competition Law Overview Format and Content This conference
More informationPatents, Standards and Antitrust: Patent Pools
Patents, Standards and Antitrust: Patent Pools Mark H. Webbink Senior Lecturing Fellow Duke University School of Law History of Patent Pools DOJ/FTC Guidelines EU Guidelines Patent Pools in the News History
More informationWorkshop on International R&D and Technology Transfer Contracts Negotiations, Intellectual Property Rights and Dispute Resolution
Workshop on International R&D and Technology Transfer Contracts Negotiations, Intellectual Property Rights and Dispute Resolution WIPO - Alicante, March 11, 2011 Agreements in R&D and Technology Transfer:
More informationFreedom to Operate (FTO) from a large company s perspective
Freedom to Operate (FTO) from a large company s perspective Dr Stoyan A. Radkov - European Patent Attorney Novartis Pharma AG, Basel, Switzerland 11 October 2010 RSC, Piccadilly, London Overview What do
More informationCurriculum Vitae. Miss Panisa Suwanmatajarn Tel: Fax:
Curriculum Vitae Miss Panisa Suwanmatajarn Tel: 66-84 -1344143 Fax: 66-2 - 2756328 E-mail: panisa79@yahoo.com Education LL.M. (IP and IT Laws) (With Merit) (2006-2007) Queen Mary, University of London,
More informationAsking Questions on Knowledge Exchange and Exploitation in the Business R&D and Innovation Survey
Asking Questions on Knowledge Exchange and Exploitation in the Business R&D and Innovation Survey John Jankowski Program Director Research & Development Statistics OECD-KNOWINNO Workshop on Measuring the
More informationRegional Seminar for Certain African Countries on the Implementation and Use of Several Patent-Related Flexibilities
REPUBLIC OF SOUTH AFRICA Regional Seminar for Certain African Countries on the Implementation and Use of Several Patent-Related Flexibilities Topic 7: Flexibilities Related to the Definition of Patentable
More information1. Protecting the work and expressing the potential of our clients' companies
Turin, December, 2012 PRESS FOLDER 1. Protecting the work and expressing the potential of our clients' companies 2. Over a century of solid experience and steady growth 3. A network of excellence 4. Leadership
More informationSHORT SUMMARY REPORT OF THE WORKSHOP ON GENETIC INVENTIONS, INTELLECTUAL PROPERTY RIGHTS AND LICENSING PRACTICES
SHORT SUMMARY REPORT OF THE WORKSHOP ON GENETIC INVENTIONS, INTELLECTUAL PROPERTY RIGHTS AND LICENSING PRACTICES Held in Berlin, Germany 24 and 25 January 2002 1 I. The Berlin Experts Workshop On January
More informationPatents, Standards and the Global Economy
Patents, Standards and the Global Economy Nikolaus Thumm 5 th Workshop The Output of R&D activities: Harnessing the Power of Patents Data Seville, 19-20 September 2013 SEPs = Standard Essential Patents
More informationVistas International Internship Program
Vistas International Internship Program Find Yourself in a Place Where challenges aren t simply accepted, but sought. This is the new age of IP. This is Knobbe Martens. Who We Are Founded in 1962, Knobbe
More informationPresentation to NAS Committee on IP Management in Standards-Setting Processes. Dan Bart President and CEO Valley View Corporation November 4, 2011
Presentation to NAS Committee on IP Management in Standards-Setting Processes Dan Bart President and CEO Valley View Corporation November 4, 2011 Who is Dan Bart? Current Chairman of the ANSI IPR Policy
More informationTrademarks. Fortune 500 companies and organizations of all sizes trust Lathrop Gage to help establish, guard, maintain and enforce trademarks.
Trademarks What's in a name? As much as 85 percent of the market capitalization of today's Fortune 500 now lies in intellectual property rather than tangible assets, and Forbes reports that trademarks
More informationBusiness Method Patents, Innovation, and Policy. Bronwyn H. Hall UC Berkeley and NBER
Business Method Patents, Innovation, and Policy Bronwyn H. Hall UC Berkeley and NBER Outline What is a business method patent? Patents and innovation Patent quality Survey of policy recommendations The
More informationFacilitating SEP Licensing -JPO's Approach- March 13, 2018 Naoko MUNAKATA Commissioner of the Japan Patent Office
Facilitating SEP Licensing -JPO's Approach- March 13, 2018 Naoko MUNAKATA Commissioner of the Japan Patent Office 1. Relation between Standards and Patents Patents Grant monopoly to a technology Tension
More informationTRIPS and Access to Medicines. WR Briefing
TRIPS and Access to Medicines WR Briefing Outline What is TRIPS How does it affect access to medicines What are the TRIPS flexibilities? What are extra-trips provisions? How do the extra-trips provisions
More informationAlgae Biomass Summit 2014: Patent Strategies for Algae Companies in an Era of Patent Reform Peter A. Jackman, Esq. October 2, 2014
Algae Biomass Summit 2014: Patent Strategies for Algae Companies in an Era of Patent Reform Peter A. Jackman, Esq. October 2, 2014 2013 Sterne, Kessler, Goldstein, & Fox P.L.L.C. All Rights Reserved. Why
More informationJPO s recent developments
JPO s recent developments IP5 Heads of Office with IP5 Industry Meetings 31 May 2017 Japan Patent Office Changes in Number of Patent Applications and Registrations Numbers of Patent Applications, Patent
More informationTRIPS, FTAs and BITs: Impact on Domestic IP- and Innovation Strategies in Developing Countries
Innovation, Creativity and IP Policy: An Indo-European Dialogue TRIPS, FTAs and BITs: Impact on Domestic IP- and Innovation Strategies in Developing Countries Henning Grosse Ruse NUJS & MPI Collaborative
More informationIntellectual Property
Intellectual Property Johnson & Johnson believes that the protection of intellectual property (IP) is essential to rewarding innovation and promoting medical advances. We are committed: to raising awareness
More informationExhaustive Training module for new Patent examiners
Exhaustive Training module for new Patent examiners In continuation with last month's appointment of 9 examiners by the Indian Patent Office, 8 more candidates have now been appointed as examiners. All
More informationIntellectual Property Policy. DNDi POLICIES
Intellectual Property Policy DNDi POLICIES DNDi hereby adopts the following intellectual property (IP) policy: I. Preamble The mission of DNDi is to develop safe, effective and affordable new treatments
More informationLarry R. Laycock. Education. Practice Focus. Attorney at Law Shareholder
Larry R. Laycock Attorney at Law Shareholder Larry has extensive experience as lead trial counsel in complex and intellectual property litigation. His practice includes patent, trademark, trade secret,
More informationThe Interdisciplinary Centre for Competition Law and Policy (ICC) and Crowell & Moring LLP Annual Conference 2009
Pub4097 ICC Conference Prog_v3.qxd 10/3/09 10:07 Page 3 The Interdisciplinary Centre for Competition Law and Policy (ICC) and Crowell & Moring LLP Annual Conference 2009 Trends and Developments in Global
More informationSEMINAR: INTELLECTUAL PROPERTY ARRANGEMENTS: IMPLICATIONS FOR DEVELOPING COUNTRY PRODUCTIVE CAPABILITIES IN THE SUPPLY OF ESSENTIAL MEDICINES.
SEMINAR: INTELLECTUAL PROPERTY ARRANGEMENTS: IMPLICATIONS FOR DEVELOPING COUNTRY PRODUCTIVE CAPABILITIES IN THE SUPPLY OF ESSENTIAL MEDICINES Report The two-day seminar was opened by Mr. Khalil Hamdani,
More informationTRIPS and Access to Medicines. The Story so far
TRIPS and Access to Medicines The Story so far TRIPS and Access to Medicines : A brief history 1981: HIV first clinically observed 1982-83: Named AIDS 1984: Discovery that it is caused by a virus 1986:
More informationTHE AMERICA INVENTS ACT NEW POST-ISSUANCE PATENT OFFICE PROCEEDINGS
THE AMERICA INVENTS ACT NEW POST-ISSUANCE PATENT OFFICE PROCEEDINGS By Sharon Israel and Kyle Friesen I. Introduction The recently enacted Leahy-Smith America Invents Act ( AIA ) 1 marks the most sweeping
More informationNational Intellectual Property Systems, Innovation and Economic Development Framework for Country Analysis. Dominique Guellec
National Intellectual Property Systems, Innovation and Economic Development Framework for Country Analysis Dominique Guellec How can IP systems best be mobilised for innovation in middle-income economies?
More information